Utilized for asthma and chronic obstructive pulmonary disease to manage airway inflammation and support breathing maintenance.
Mechanism of Action
This combination utilizes budesonide to suppress airway inflammation and formoterol to stimulate beta-2 receptors for prolonged bronchodilation. This dual action targets both the inflammatory and constrictive components of respiratory disease.
Route of Administration
Inhalation
Onset Time
15 minutes
Duration
12 hours
Contraindications
Status asthmaticus, Hypersensitivity to any component
Information related to Budesonide Formoterol Inhaler is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
